Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
| CGRIX Fund | USD 72.72 0.08 0.11% |
Slightly above 55% of Calamos Growth's investor base is interested to short. The analysis of overall sentiment of trading Calamos Growth Fund mutual fund suggests that many investors are impartial at this time. Calamos Growth's investing sentiment can be driven by a variety of factors including economic data, Calamos Growth's earnings reports, geopolitical events, and overall market trends.
Calamos |
Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 IND enabling studies underway, with Phase I initiation expected in Q425Webcast and conference call to be held today at 430 pm ET
Read at newswire.com
 |
Calamos Growth Fundamental Analysis
We analyze Calamos Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calamos Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calamos Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Calamos Growth is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Calamos Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calamos Growth mutual fund to make a market-neutral strategy. Peer analysis of Calamos Growth could also be used in its relative valuation, which is a method of valuing Calamos Growth by comparing valuation metrics with similar companies.
Peers
Calamos Growth Related Equities
| SROCX | Calamos Antetokounmpo | 0.32 | ||||
| SROIX | Calamos Antetokounmpo | 0.31 | ||||
| CVAAX | Calamos Opportunistic | 0.22 | ||||
| CVACX | Calamos Opportunistic | 0.21 | ||||
| CVGCX | Calamos Growth | 0.12 | ||||
| CVLCX | Calamos Global | 0.09 | ||||
| CVLOX | Calamos Global | 0.08 | ||||
| CVGRX | Calamos Growth | 0.11 | ||||
| CVAIX | Calamos Opportunistic | 0.21 | ||||
| SRORX | Calamos Antetokounmpo | 0.39 |
Other Information on Investing in Calamos Mutual Fund
Calamos Growth financial ratios help investors to determine whether Calamos Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Calamos with respect to the benefits of owning Calamos Growth security.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |